Medicare beneficiaries with heart disease or major cardiovascular risk factors reported less cost-related medication ...

Approval in moderate-to-severe patients was based on pivotal trial results showing over four times more Dupixent patients experienced sustained disease remission through Week 36 compared with placebo ...

Sanofi and Regeneron's Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid Approval in moderate-to-severe patients was based on pivotal study results show ...

Approval in moderate-to-severe patients was based on pivotal trial results showing over four times more Dupixent patients experienced sustained disease remission through Week 36 compared with placebo ...

Three Tampa Bay cities were just named in the nation’s top Allergy Capitals for 2026 by the Asthma and Allergy Foundation of ...

Mike Florio and Chris Simms react to Cam Skattebo’s comments about CTE and asthma, discussing why some NFL players have a ...

Adults with chronic spontaneous urticaria symptoms despite antihistamine use had reductions in disease activity with LP-003, a novel anti-IgE antibody, vs. placebo and omalizumab, according to phase 2 ...

Higher blood pressure during young adulthood is likely linked to a higher risk of heart disease and kidney disease later in ...

Adults ages 50 through 64 saw health care costs skyrocket after Obamacare subsidies faded. Now some are delaying care until ...

Warmer temperatures will cause an early, strong season with high tree pollen levels moving north from the South and Ohio ...

A new Phase 2 clinical study is now enrolling adults with moderate to severe asthma to evaluate the safety and efficacy of ...

Respiratory specialist nurse Maria Eurton discusses case examples to explain how to approach common diagnostic challenges in ...